In this study, the molecular subtypes Luminal B and HER-2 overexpressed sentinel lymph node metastasis rates were higher (42.77% and 43.75%, respectively), compared with Luminal A (22.98%) and triple negative (18.87%). Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.